Allakos Performance
| ALLKDelisted Stock | USD 0.33 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Allakos are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Allakos has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent essential indicators, Allakos is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 67.9 M | |
| Free Cash Flow | -93.7 M |
Allakos |
Allakos Relative Risk vs. Return Landscape
If you would invest 33.00 in Allakos on November 19, 2025 and sell it today you would earn a total of 0.00 from holding Allakos or generate 0.0% return on investment over 90 days. Allakos is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Allakos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Allakos Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Allakos for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Allakos can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Allakos is not yet fully synchronised with the market data | |
| Allakos has some characteristics of a very speculative penny stock | |
| Allakos has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (115.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Allakos currently holds about 212.44 M in cash with (93.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
Allakos Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Allakos Stock often depends not only on the future outlook of the current and potential Allakos' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Allakos' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 88.8 M | |
| Cash And Short Term Investments | 80.8 M |
Allakos Fundamentals Growth
Allakos Stock prices reflect investors' perceptions of the future prospects and financial health of Allakos, and Allakos fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Allakos Stock performance.
| Return On Equity | -0.89 | |||
| Return On Asset | -0.53 | |||
| Current Valuation | (46.92 M) | |||
| Shares Outstanding | 90.38 M | |||
| Price To Earning | (21.26) X | |||
| Price To Book | 0.54 X | |||
| EBITDA | (108.09 M) | |||
| Cash And Equivalents | 212.44 M | |||
| Cash Per Share | 3.87 X | |||
| Total Debt | 4.16 M | |||
| Debt To Equity | 0.23 % | |||
| Book Value Per Share | 0.61 X | |||
| Cash Flow From Operations | (93.62 M) | |||
| Earnings Per Share | (0.78) X | |||
| Total Asset | 96.6 M | |||
| Retained Earnings | (1.23 B) | |||
| Current Asset | 37.1 M | |||
| Current Liabilities | 3.08 M | |||
About Allakos Performance
By examining Allakos' fundamental ratios, stakeholders can obtain critical insights into Allakos' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Allakos is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California. Allakos operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 192 people.Things to note about Allakos performance evaluation
Checking the ongoing alerts about Allakos for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Allakos help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Allakos is not yet fully synchronised with the market data | |
| Allakos has some characteristics of a very speculative penny stock | |
| Allakos has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (115.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Allakos currently holds about 212.44 M in cash with (93.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Allakos' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Allakos' stock is overvalued or undervalued compared to its peers.
- Examining Allakos' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Allakos' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Allakos' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Allakos' stock. These opinions can provide insight into Allakos' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Allakos Stock
If you are still planning to invest in Allakos check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allakos' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |